Moderna, Inc.
MRNA
$53.57
$1.863.60%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 26.25% | -1,638.46% | 35.50% | 17.36% | -616.13% |
| Total Depreciation and Amortization | 11.67% | 0.00% | 39.02% | 8.33% | -70.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.16% | 21.43% | 32.73% | 17.78% | 116.93% |
| Change in Net Operating Assets | -10.25% | 52.69% | -103.42% | -451.67% | 61.28% |
| Cash from Operations | 12.73% | 45.91% | 27.86% | -4.85% | 32.64% |
| Capital Expenditure | 92.53% | 78.15% | 98.35% | 40.31% | -137.27% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 47.06% | -15.94% | -69.03% | 169.75% | 94.65% |
| Cash from Investing | 91.09% | -2.91% | -65.80% | 518.64% | -0.19% |
| Total Debt Issued | 15,100.00% | -- | -300.00% | -- | -- |
| Total Debt Repaid | -20.00% | -- | -400.00% | -- | 91.94% |
| Issuance of Common Stock | 45.45% | -75.00% | -56.25% | -80.00% | -26.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 19,466.67% | -109.09% | -73.53% | -71.43% | 97.25% |
| Foreign Exchange rate Adjustments | 100.00% | 0.00% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 418.79% | 82.35% | -184.35% | 64.64% | 1,228.00% |